Tender

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Compounded mAbs - Cancer Therapies

Berkshire Healthcare NHS Foundation Trust

This public procurement record has 2 releases in its history.

TenderUpdate

12 May 2026 at 09:47

UK4 - Tender Notice
Tender

07 May 2026 at 16:42

UK4 - Tender Notice
Summary of the contracting process

The procurement process involves the Berkshire Healthcare NHS Foundation Trust as the buying organisation, seeking suppliers for a framework agreement titled "Compounded mAbs - Cancer Therapies". This initiative is set in the industry category of pharmaceutical products and services and is located across various NHS Trusts in the South East of England. The procurement is currently in the tender stage, with key deadlines including the enquiry period closing on 16th June 2026, and the tender submission deadline set for 22nd June 2026. The framework is structured into two lots: Lot 1 for high-volume products and Lot 2 for lower-volume products, each with an active contract period starting on 1st December 2026 and extending through to 30th November 2028, with options for renewal.

This tender represents a significant opportunity for businesses involved in the pharmaceutical sector, particularly those specialising in monoclonal antibodies for chemotherapy treatments. Suitably positioned small and medium-sized enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs) can leverage this open procurement procedure to secure a place in the framework. The opportunity facilitates business growth through a potential framework value of £216 million, providing a stable pipeline of demand over several years. Businesses capable of meeting technical compliance, quality assurance benchmarks, and competitive pricing criteria are well-suited to compete, with the procurement process allowing for new players to enter the market.

How relevant is this notice?

Notice Information

Notice Title

Compounded mAbs - Cancer Therapies

Notice Description

Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters' Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framework via MPSC. Please note: we did not publish a preliminary market engagement notice (UK2) for the following reasons: - we are not seeking to further develop our requirements or procurement approach. - we have procured similar supply arrangements via the Open procedure and deployed similar conditions of participation and award criteria. These have yielded good results previously. - we have already prepared our tender pack (see attached), that detail standard NHS contractual terms which have been found to be acceptable to the supply chain. - we understand the likely suppliers who will be interested but the open notice approach gives opportunity to others looking to enter the mAbs supply market

Lot Information

Lot 1

High Volume Products - 5 molecules / all brands

Options: Option for 2 x 12 month extension (maximum duration 4 years).

Renewal: Option for 2 x 12 month extension (maximum duration 4 years).

Lot 2

Lower Volume Products - 13 molecules / all brands

Options: Option for 2 x 12 month extension (maximum duration 4 years).

Renewal: Option for 2 x 12 month extension (maximum duration 4 years).

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0693de
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/043323-2026
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
UK4 - Tender Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME, VCSE
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

85 - Health and social work services

CPV Codes

33600000 - Pharmaceutical products

85149000 - Pharmacy services

Notice Value(s)

Tender Value
£216,000,000 £100M-£1B
Lots Value
£216,000,000 £100M-£1B
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
12 May 20264 months ago
Submission Deadline
22 Jun 2026Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Dec 2026 - 30 Nov 2028 2-3 years
Recurrence
2029-07-02

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Berkshire Healthcare NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRACKNELL
Postcode
RG12 2UT
Postcode Area
Reading
Country
England
Major Region (ITL 1)
TLJ South East (England)
Basic Region (ITL 2)
TLJ1 Berkshire, Buckinghamshire and Oxfordshire
Small Region (ITL 3)
TLJ15 Berkshire East
Delivery Location
TLJ South East (England)
Local Authority
Bracknell Forest
Electoral Ward
Bullbrook
Westminster Constituency
Bracknell

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...